Dino's Bar & Grill Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Goose94	5/19/2019 5:44:55 AM
	Read Replies (2) of 202923

Microbix Biosystems (MBX-T) top pick from Robert McWhirter on BNN.ca Market Call Friday May 17th @ 1200ET The enterprise value manufactures over 30 viral and bacterial antigens and cell, culture-based biological products used for medical testing. Over the past two years MBX has spent $3 million for efficient bio reactors which will increase three times capacity and are expected to boost annual bottom line profitability by $1 million by the end of 2019. Combined with the $1.56 million of Q2 annualized net income gives a cheap 13.3 times price-to-earnings exit 2019 run rate ($2.56/$34 million fully diluted market cap). In February I joined the CDC’s HPV webinar to hear Jason Mendelsohn’s story of his HPV oral cancer battle. MedX Health’s FDA approved light therapy speeds post chemo tissue healing for HPV oral cancer patients. Microbix could do ISO 13485 self-affirmation of controls for three HPV strains with the annual potential of one million HPV tests leading to potential additional recurring income of $0.8 million per year.($0.4 million in 2020).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next